New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin

Publisher： Karger

E-ISSN： 1421-9794|62|1|62-70

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.1, 2016-09, pp. : 62-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer

By  

Chemotherapy, Vol. 59, Iss. 2, 2013-09 ,pp. : 106-111

Karger

Access to resources Recommend Favorite

Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 197-203

Karger

Access to resources Recommend Favorite

Successful Preoperative Chemotherapy with S-1 plus Low-Dose Cisplatin for Advanced Gastric Cancer with Synchronous Liver Metastases: Report of 2 Cases

By  

Chemotherapy, Vol. 53, Iss. 5, 2007-09 ,pp. : 378-382

Karger

Access to resources Recommend Favorite

A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 6, 2013-01 ,pp. : 454-460

Karger

Access to resources Recommend Favorite

Phase I/II Trial of Irinotecan and S-1 Combination Chemotherapy as a Second-Line Treatment for Advanced Colorectal Cancer

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 338-343

Karger

Access to resources Recommend Favorite